Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter SATB2 Antikörper (AA 200-300)

Dieses Kaninchen Monoklonal-Antikörper erkennt spezifisch SATB2 in IHC (f). Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN7126418

Kurzübersicht für Rekombinanter SATB2 Antikörper (AA 200-300) (ABIN7126418)

Target

Alle SATB2 Antikörper anzeigen
SATB2 (SATB Homeobox 2 (SATB2))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 66
  • 35
  • 30
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 58
  • 8
Kaninchen

Klonalität

  • 44
  • 22
Monoklonal

Konjugat

  • 36
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser SATB2 Antikörper ist unkonjugiert

Applikation

  • 46
  • 21
  • 15
  • 15
  • 13
  • 13
  • 9
  • 7
  • 7
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Bindungsspezifität

    • 16
    • 8
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 200-300

    Spezifität

    SATB2 is a DNA binding protein that specifically binds nuclear matrix attachment regions. It is involved in transcription regulation and chromatin remodeling. SATB2 expression in colorectal carcinomas (CRC) is correlated with good prognosis and in laryngeal squamous cell carcinoma it functions as a tumor suppressor wherein loss of expression is positively correlated with high tumor grade and recurrence. Moreover, SATB2, in combination with CK20, could identify almost all CRC s. Upper gastrointestinal (GI) carcinomas and pancreatic ductal carcinomas are usually negative for SATB2, and ovarian carcinomas, lung adenocarcinomas, and adenocarcinomas from other origin are rarely positive for SATB2. Additionally, SATB2 antibody can identify neuroendocrine neoplasms of colon and rectum because SATB2 is usually negative in neuroendocrine neoplasms of the GI tract, pancreas, and lung. More recently, it has been reported that SATB2 is a sensitive marker for tumors with osteoblastic differentiation.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Synthetic peptide corresponding to residues within aa200-300 corresponding to human SATB2

    Isotyp

    IgG
  • Applikationshinweise

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Human colon or cerebral cortex tissue.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    SATB2 (SATB Homeobox 2 (SATB2))

    Andere Bezeichnung

    SATB2

    Hintergrund

    DNA-binding protein SATB2, GLSS, SATB homeobox 2, Special AT-rich sequence-binding protein 2,SATB2 (Colorectal Carcinoma Marker)
    Cellular localisation: Nuclear

    Molekulargewicht

    83kDa

    Gen-ID

    23314, 516617

    UniProt

    Q9UPW6
Sie sind hier:
Chat with us!